Structural requirements for the complement regulatory activities of C4BP

被引:113
作者
Blom, AM [1 ]
Kask, L [1 ]
Dahlbäck, B [1 ]
机构
[1] Univ Lund, Malmo Univ Hosp, Wallenberg Lab, Dept Clin Chem, S-20502 Malmo, Sweden
关键词
D O I
10.1074/jbc.M102445200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
C4b-binding protein (C4BP) is a regulator of the classical complement pathway C3 convertase (C4bC2a complex). It is a disulfide-linked polymer of seven cr-chains and a unique beta -chain; the alpha- and beta -chains are composed of eight and three complement control protein (CCP) domains, respectively. To elucidate the importance of the polymeric nature of C4BP and the structural requirements for the interaction between C4b and the alpha -chain, 19 recombinant C4BP variants were created. Six truncated monomeric variants, nine polymeric variants in which individual CCPs were deleted, and finally, four variants in which double alanine residues were introduced between CCPs were functionally characterized. The smallest truncated C4BP variant still active in regulating fluid phase C4b comprised CCPI-3, The monomeric variants were less efficient than polymeric C4BP in degrading C4b on cell surfaces. All three N-terminal CCP domains contributed to the binding of C4b and mere important for full functional activity; CCP2 and CCPS were the most important. The spatial arrangements of the first CCPs were found to be important, as introduction of alanine residues between CCPs 1 and 2, CCPs 2 and 3, and CCPs 3 and 4 resulted in functional impairment. The results presented here elucidate the structural requirements of individual CCPs of C4BP, as well as their spatial arrangements within and between subunits for expression of full functional activity.
引用
收藏
页码:27136 / 27144
页数:9
相关论文
共 45 条
  • [1] Accardo P, 1996, J IMMUNOL, V157, P4935
  • [2] ADAMS EM, 1991, J IMMUNOL, V147, P3005
  • [3] LOCALIZATION OF THE COMPLEMENT-COMPONENT-C3B-BINDING SITE AND THE COFACTOR ACTIVITY FOR FACTOR-I IN THE 38KDA TRYPTIC FRAGMENT OF FACTOR-H
    ALSENZ, J
    LAMBRIS, JD
    SCHULZ, TF
    DIERICH, MP
    [J]. BIOCHEMICAL JOURNAL, 1984, 224 (02) : 389 - 398
  • [4] INHIBITION OF COMPLEMENT COMPONENTS C3 AND C4 BY CADRALAZINE AND ITS ACTIVE METABOLITE
    ANDERSSON, M
    HANSON, A
    ENGLUND, G
    DAHLBACK, B
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 (03) : 261 - 265
  • [5] Berggard K, 1997, INFECT IMMUN, V65, P3638
  • [6] Positively charged amino acids at the interface between α-chain CCP1 and CCP2 of C4BP are required for regulation of the classical C3-convertase
    Blom, AM
    Zadura, AF
    Villoutreix, BO
    Dahlbäck, B
    [J]. MOLECULAR IMMUNOLOGY, 2000, 37 (08) : 445 - 453
  • [7] Human C4b-binding protein has overlapping, but not identical, binding sites for C4b and streptococcal M proteins
    Blom, AM
    Berggård, K
    Webb, JH
    Lindahl, G
    Villoutreix, BO
    Dahlbäck, B
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (10) : 5328 - 5336
  • [8] A cluster of positively charged amino acids in the C4BP α-chain is crucial for C4b binding and factor I cofactor function
    Blom, AM
    Webb, J
    Villoutreix, BO
    Dahlbäck, B
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (27) : 19237 - 19245
  • [9] Brodbeck WG, 1996, J IMMUNOL, V156, P2528
  • [10] STRUCTURAL AND FUNCTIONAL-STUDIES ON C4B-BINDING PROTEIN, A REGULATORY COMPONENT OF THE HUMAN-COMPLEMENT SYSTEM
    CHUNG, LP
    REID, KBM
    [J]. BIOSCIENCE REPORTS, 1985, 5 (10-11) : 855 - 865